Few countries in the Region have effectively implemented
generic policies with strong regulatory requirements in combination
with incentives for the development of the generic markets, acceptance,
and rational generic drug use, hindering access to the most cost-effective
public health commodities required for the provision of primary care.
Promoting the use of incentives to increase the availability
and affordability of generics, as well as incentives aimed at the
prescriber and user to improve acceptance, will provide countries
in the Region with options in the development and implementation of
policy.
